Modern science, ancient materials, and a mission beyond the wound
DiasilX is a Germany-based medtech project rethinking what materials can do in diabetic wound care.
We are not just looking for another new ingredient
We are not just looking for another new ingredient. We are rethinking what a material itself can do.
In an age that often reaches for more complex molecules and more expensive technologies, DiasilX returns to an older and quieter starting point: materials left by nature.
We are not going back to the past. We use modern science to understand ancient materials again, define them with discipline, and bring them back to today's medical-device pathway under today's standards.
Nature gave it shape.Time gave it silence.Germany gives it discipline.DiasilX gives it a new mission.
Germany
2026 · Pre-seed stage
EU MDR Class IIa medical device · Diabetic foot ulcers
IP workstreams in preparation · selected pathways under review
Staged operating model
DiasilX is preparing a staged operating structure. Product development, regulatory planning, testing partnerships, and manufacturing options are handled under milestone-based review.
This staged model supports EU MDR performance-evaluation planning and selected international regulatory pathway review.
Our technology development is supported by computational analysis workflows, image-based material characterization, and third-party testing partnerships with established CROs.